The board of directors at Connect Biopharma have experience in a variety of industries, including law and medicine. They have also studied at some of the top schools in the country, including Columbia Law School and Stanford University. This experience and education gives them the ability to provide valuable insights and guidance to the company.
Brian G. Feagan
Scientific Advisor
Bruce E. Strober
Scientific Advisor
David T. Rubin
Scientific Advisor
Derek Dirocco
Board Director
Edward M. Kerwin
Scientific Advisor
Emma Guttman-Yassky
Scientific Advisor
Jean Liu
Board Director
John V. Fahy
Scientific Advisor
Kan Chen
Board Director
Karen J. Wilson
Board Director
Kleanthis G. Xanthop...
Board Director
Stuart J. Swiedler
Scientific Advisor
View all